The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation
Y Aoki, NM Walker, K Misumi, T Mimura, R Vittal… - The Journal of Heart and …, 2023 - Elsevier
Background Small airway inflammation and fibrosis or bronchiolitis obliterans (BO) is the
predominant presentation of chronic lung allograft dysfunction (CLAD) post-lung …
predominant presentation of chronic lung allograft dysfunction (CLAD) post-lung …
The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation
Y Aoki, NM Walker, K Misumi, T Mimura… - The Journal of Heart …, 2023 - jhltonline.org
Background Small airway inflammation and fibrosis or bronchiolitis obliterans (BO) is the
predominant presentation of chronic lung allograft dysfunction (CLAD) post-lung …
predominant presentation of chronic lung allograft dysfunction (CLAD) post-lung …
The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation.
Y Aoki, NM Walker, K Misumi, T Mimura… - The Journal of Heart …, 2022 - europepmc.org
Background Small airway inflammation and fibrosis or bronchiolitis obliterans (BO) is the
predominant presentation of chronic lung allograft dysfunction (CLAD) post-lung …
predominant presentation of chronic lung allograft dysfunction (CLAD) post-lung …
The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation
Y Aoki, NM Walker, K Misumi… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Small airway inflammation and fibrosis or bronchiolitis obliterans (BO) is the
predominant presentation of chronic lung allograft dysfunction (CLAD) post-lung …
predominant presentation of chronic lung allograft dysfunction (CLAD) post-lung …